Loading provider…
Loading provider…
Hematology & Oncology Physician in Los Angeles, CA
NPI: 1659303873Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get MD Greg's Phone Numberphone_androidMobile
Get MD Greg's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2011 - 2027
CT State Medical License
2004 - 2011
MD State Medical License
2001 - 2004

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology
Johns Hopkins University
Fellowship • Hematology and Medical Oncology
2001 - 2004
WashU Medicine
medicine.washu.edu
Medical School
Until 1997
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
1997 - 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 459 | 954 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 361 | 1,027 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 103 | 292 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 98 | 98 |
| 5 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 62 | 83 |
Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.
Authors: Greg R. Angstreich, B. Douglas Smith, Richard J. Jones
Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.
Authors: Carol Huff, William Matsui
Journal: Br J Haematol
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Biomarker Analysis, OTHER: Cytology Specimen Collection Procedure
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, DRUG: Axitinib, BIOLOGICAL: Anti-OX40 Antibody PF-04518600
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Computed Tomography